The value of a moratorium on consumer ads for new drugs would hinge on whether a reduction in unexpected side effects outweighed lost health benefits from reduced use of effective medicines, a Congressional Budget Office report says.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/05/27/136707432/curbs-on-ads-for-new-drugs-could-be-a-mixed-bag?ft=1&f=103537970
Posted
May 27 2011, 05:36 AM
by
NPR Blogs: Shots - Health Blog